✨ Your Portfolio is fetched and updated from zerodha.
Nano Pharmaceuticals

Kabra Drugs Ltd.

KABRADG

Get real time AI alerts about this company on your WhatsApp!
Market Cap
₹42 Cr.
P/E
0.00

Kabra Drugs Ltd.

  • Kabra Drugs
  • Medistep Healthcare
  • JFL Life Sciences

FAQs on Kabra Drugs Ltd. Shareprice

Kabra Drugs has given better returns compared to its competitors.
Kabra Drugs has grown at ~96.61% over the last 1yrs while peers have grown at a median rate of -35.0%

Kabra Drugs is not expensive.
Latest PE of Kabra Drugs is 0.0, while 3 year average PE is 10.6.
Also latest EV/EBITDA of Kabra Drugs is 0.0 while 3yr average is 18.32.

View FAQ's On Business

Growth Table

  • Kabra Drugs Ltd.
  • Medistep Healthcare
  • JFL Life Sciences

Balance Sheet

  • Kabra Drugs Ltd.
  • Medistep Healthcare
  • JFL Life Sciences

Balance Sheet Snapshot

No data available.

Fund Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end

Profit & Loss

  • Kabra Drugs Ltd.
  • Medistep Healthcare
  • JFL Life Sciences

Cash Flow

  • Kabra Drugs Ltd.
  • Medistep Healthcare
  • JFL Life Sciences

Cash Flow Analysis

  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.

Ratios

= Dominant Factor
  • Kabra Drugs Ltd.
  • Medistep Healthcare
  • JFL Life Sciences

Quarterly Results

  • Kabra Drugs Ltd.
  • Medistep Healthcare
  • JFL Life Sciences

Reverse DCF

locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Raphson method.
Learn how to use Reverse DCF

FAQs on Kabra Drugs Ltd. Financials

Kabra Drugs balance sheet is weak and might have solvency issues

The net debt of Kabra Drugs is decreasing.
Latest net debt of Kabra Drugs is -₹20.86 Crs as of Mar-25.
This is less than Mar-24 when it was -₹3.52 Crs.

No, profit is decreasing.
The profit of Kabra Drugs is -₹1.04 Crs for TTM, -₹0.74 Crs for Mar 2024 and -₹0.34 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Kabra Drugs latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are allocated to majorly unproductive assets like Cash & Short Term Investments, Short Term Loans & Advances

View FAQ's On Shareholding
Ideas Dashboard
Results
Timeline
Watchlist
Portfolio
Alerts
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech